General Biotechnology

Will R&D Make Merck Hot Again? The drug giant gets out of the prescription business and bets it all on […]

Will R&D Make Merck Hot Again? The drug giant gets out of the prescription business and bets it all on

Cracking the cancer code Whether a tumor invades the lung or breast is beside the point. Its genetic activity will

Report raps drug firms’ ‘post-approval’ studies Drug manufacturers spent $1.5 billion in 2000 to test medicines already approved by the

Report raps drug firms’ ‘post-approval’ studies Drug manufacturers spent $1.5 billion in 2000 to test medicines already approved by the

Of Clones and Clowns A distinguished molecular biologist discusses the “cloning circus” and the damage it is doing to serious

Legal Circumvention Molecular switches provide a route around existing gene patents

5 Big Drug Companies Face R&D Drought Five of the world’s biggest drug companies do not have any potential billion-dollar

5 Big Drug Companies Face R&D Drought Five of the world’s biggest drug companies do not have any potential billion-dollar

Informatics Moves to the Head of the Class The race is on to increase the quantity and quality of bio-IT